drugset / Trial / NCT05927415
A Study to Test How Kidney Problems Influence the Blood Concentrations of Efgartigimod
Non-randomizedParallel-groupOpen-labelOther
Summary
A study to test how kidney problems influence the blood concentrations of efgartigimod
Timeline
- Start
- 2023-07-17
- Primary completion
- 2024-06-12
- Completion
- 2024-06-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Efgartigimod Alfa | Protein / enzyme biologic | 10 mg/kg | Intravenous |